On November 16, 2017, the U.S. Food and Drug Administration released several guidance documents to provide sponsors and device manufacturers engaged in the development of regenerative medicine products, including novel cellular therapies, with the Agency's current thinking regarding evaluation of devices use in the recovery, isolation or delivery of regenerative medicines advanced therapies (RMAT).
New to research or just need a refresher? Review animal research glossaries and commonly used acronyms in animal research.
Exposure to research animals can include risk to visitors and research animals. Check all guidelines and regulations for visitors.